Retrophin Inc (RTRX)

23.66
0.39 1.70
NASDAQ : Health Care
Prev Close 23.27
Open 23.25
Day Low/High 23.25 / 23.73
52 Wk Low/High 11.60 / 37.04
Volume 578.06K
Avg Volume 293.70K
Exchange NASDAQ
Shares Outstanding 38.39M
Market Cap 863.67M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Martin Shkreli, "The Most Hated Man in America," Was Just Convicted on 3 Counts of Securities Fraud

Martin Shkreli, "The Most Hated Man in America," Was Just Convicted on 3 Counts of Securities Fraud

"Pharma bro" Martin Shkreli was found guilty on three of eight counts of securities fraud.

Retrophin Commences Patient Dosing In International, Registrational Phase 3 Trial Of RE-024 In PKAN

Retrophin Commences Patient Dosing In International, Registrational Phase 3 Trial Of RE-024 In PKAN

FORT Study to assess efficacy and safety of novel replacement therapy

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

Sarah Hassan, daughter of pharmaceutical executive Fred Hassan, was ignored by Shkreli for nearly a year before she received returns on her original investment.

Juror Selection In Martin Shkreli Case Drags Into a Third Day

Juror Selection In Martin Shkreli Case Drags Into a Third Day

More than 250 jurors have been interviewed, but there's still no luck in assembling a jury for the so-called 'Pharma Bro.'

First Amendment Needs to 'Take a Backseat' in Pharma Bro Trial: Lawyer

First Amendment Needs to 'Take a Backseat' in Pharma Bro Trial: Lawyer

The 'Pharma Bro's' lawyer attempts to bar the press again from 'Pharma Bro's' hearing.

Commit To Purchase Retrophin At $12.50, Earn 10.4% Using Options

Commit To Purchase Retrophin At $12.50, Earn 10.4% Using Options

Investors eyeing a purchase of Retrophin, Inc. stock, but cautious about paying the going market price of $19.48/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Potential Jurors Lambaste 'Pharma Bro' Shkreli as Judge Calls 180 People to Fill Just 18 Spots

Potential Jurors Lambaste 'Pharma Bro' Shkreli as Judge Calls 180 People to Fill Just 18 Spots

One juror said Shkreli is 'the face of corporate greed in America.'

Pharma Bro's Trial to Begin Monday

Pharma Bro's Trial to Begin Monday

The trial for Martin Shkreli, the man alleged to have cheated investors and increasing a medication price by 5,000%, will begin today.

Relative Strength Alert For Retrophin

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADGE, ANTX, HY, RTRX, VNDA Downgrades: CELP, FORD, GRC, HMSY, LNCE, MET, NCI, OUT, PLPC, UBA Initiations: ADAP, DGLT Read on to get TheStreet Quant Ratings' detailed report:

RSI Alert: Retrophin (RTRX) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of RTRX February 17th Options Trading

First Week of RTRX February 17th Options Trading

Investors in Retrophin, Inc. saw new options begin trading this week, for the February 17th expiration.